Fuze Health
PrivateLast Round
Series D
Extension
Sep 8, 2022
Est. Valuation
$1.6B
Total Funding Raised
$541.8M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Fuze Health is a healthcare technology company that provides an integrated platform for personalized home healthcare, including diagnostics, virtual care, and pharmacy services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Pharma Supply Chain, Patient Engagement, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fuze Health Comparables
Compare Fuze Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Everly Health | 74% | |
| HealthDyne | 73% | |
| EVERSANA | 70% |
Fuze Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Sep 8, 2022 | ||||
| Series D | Oct 27, 2021 | ||||
| Series D | Jun 8, 2021 | ||||
| Series C | Sep 9, 2020 | ||||
| Series B | Jul 8, 2020 | ||||
Series C | May 6, 2020 |
Key People
Founding team and executive leadership
Fuze Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Slow Ventures | Seed |
| Deerfield Management | Series C |
| Transpose Platform Management | Series C, Series D, Series B |
| Oak HC/FT | Series C |
| Tuesday Capital | Series A |
| Optum Ventures | Series C, Series B, Series D, Series A |
| Morgan Health | Series D Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 18, 2026
Grew 28% QoQ, from 149 to 190 employees.
- Jul 26, 2026
Monthly visitors increased 32% MoM to 92.6K.
Fuze Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fuze Health's valuation, stock price, and market status.
Is Fuze Health a public or private company?
Fuze Health is a private company.
What is the current stock price of Fuze Health?
Fuze Health is a private company with no public stock price. No recent secondary market data is available.
How much is Fuze Health worth (valuation)?
Fuze Health's valuation is estimated at $1.6B based on funding round data.
Can I buy Fuze Health stock?
Fuze Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Fuze Health's last funding round?
Fuze Health's most recent funding round was Series D Extension on October 27, 2021.
Who are the main investors in Fuze Health?
Key investors in Fuze Health include Oak HC/FT, Optum Ventures, HLM Investment Partners, Initialized Capital Management, Casdin Capital.
Will Fuze Health IPO soon?
No public IPO plans have been announced for Fuze Health.
How can I track Fuze Health secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fuze Health's secondary market activity and sign up for updates.